New Chemotherapy Protocol (P-CAN) for Treatment of Aggressive Non-Hodgkin's Lymphoma
I. R. Kakil(Hamad Medical Corporation), Abdülbari Bener(University of Manchester), A. Chong‐Lopez, Abdalla Awidi(University of Jordan), Ussama Al Homsi(Hamad Medical Corporation), Ahmed A. Mubarak(Hamad Medical Corporation), Amir A Hassan, Mohammed Kelta
Cited by 0
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123
Newborn Population Screening for Classic Homocystinuria by Determination of Total Homocysteine from Guthrie Cards
|The Journal of Pediatrics|2009|111